二、 回购股份的进展情况 证券代码：688535 证券简称：华海诚科 公告编号：2025-010 江苏华海诚科新材料股份有限公司 关于股份回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/12/31 | | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 12 个月 | | 预计回购金额 | 万元 2,500 万元~5,000 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | √用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | 万股 7.18 | | 累计已回购股数占总股本比 | 0.09% | | 例 | | | 累计已回购金额 | 万元 599.97 | | 实际回购价格区间 | 81.18 元/股~86.56 元/股 | 一、 回购股份的基本情况 江苏华海诚科新材料股份有限公司（以下简称"公司"）于 2024 年 12 月 27 日 召开第三届董事会第二十一次会议，审 ...

证券代码:688535 证券简称:华海诚科 公告编号:2025-008 江苏华海诚科新材料股份有限公司 关于筹划发行股份、可转换公司债券及支付现金购买资产 并募集配套资金事项的进展公告 2024 年 11 月 24 日,公司召开第三届董事会第二十次会议、第三届监事会第 十八次会议,审议通过了《关于公司本次发行股份、可转换公司债券及支付现金 购买资产并募集配套资金的议案》等与本次交易相关的议案,具体内容详见公司 2024 年 11 月 26 日刊登在上海证券交易所网站(www.sse.com.cn)的《江苏华海 诚科新材料股份有限公司发行股份、可转换公司债券及支付现金购买资产并募集 配套资金预案》及相关公告。同日,公司披露了《江苏华海诚科新材料股份有限 公司关于披露发行股份、可转换公司债券及支付现金购买资产并募集配套资金预 案的一般风险提示暨公司股票复牌的公告》(公告编号:2024-052),公司股票 2024 年 11 月 26 日开市起复牌。 2025 年 1 月 3 日，公司披露了《江苏华海诚科新材料股份有限公司关于筹 划重大资产重组事项的进展公告》（公告编号：2025-001），具体内容详见公司同 日刊 ...

Financial Performance - Total operating revenue for 2024 reached RMB 331.59 million, an increase of 17.21% compared to the previous year[3] - Net profit attributable to shareholders of the parent company was RMB 40.80 million, up 28.97% year-on-year[5] - The net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, was RMB 34.85 million, reflecting a growth of 27.22%[5] - Basic earnings per share increased to RMB 0.51, representing a growth of 21.43%[3] - The weighted average return on net assets rose to 3.96%, an increase of 0.28 percentage points[3] Assets and Equity - The company's total assets at the end of the reporting period were RMB 1,404.47 million, a 14.14% increase from the beginning of the period[4] - Shareholders' equity attributable to the parent company was RMB 1,039.82 million, up 1.22% from the beginning of the period[4] Operational Factors - The increase in operating profit by 32.32% was primarily due to the growth in product sales revenue and further optimization of product structure[7] - The semiconductor industry experienced an upward cycle, contributing to increased orders and improved capacity utilization[5] - The domestic substitution process for high-performance epoxy molding compounds accelerated, positively impacting revenue and profit growth[5]

Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside in the stock price [5][11]. Core Insights - The company is a leading player in the epoxy encapsulation materials sector, with a significant market presence in both traditional and advanced packaging fields. It is set to enhance its competitive edge through the acquisition of Hengsuo Huawai, the top domestic supplier of epoxy encapsulation materials, which will position the company as the second-largest supplier globally [5][9]. - The company has achieved a notable level of product quality comparable to foreign manufacturers in the traditional packaging sector and is gradually replacing foreign products in key client accounts [7][9]. - The company’s revenue from the epoxy encapsulation materials segment reached 149 million RMB in the first half of 2024, accounting for 95.72% of total revenue, with a gross margin of 27.40% [7]. Company Overview - The company was established in 2010 and went public on the Sci-Tech Innovation Board in April 2023. Its primary product, epoxy encapsulation materials (EMC), is widely used in semiconductor packaging [7]. - The company has a diverse customer base, including major domestic packaging firms such as Changdian Technology and Huatian Technology [7]. - The company is also involved in the electronic adhesive market, which complements its EMC business, with a revenue contribution of 622,000 RMB in the first half of 2024 [11]. Financial Performance - The company reported a net profit of 32 million RMB in 2023, with projections of 46 million RMB in 2024 and 63 million RMB in 2025, reflecting a year-on-year growth of 44.26% and 39.07% respectively [10]. - The earnings per share (EPS) are expected to increase from 0.39 RMB in 2023 to 0.57 RMB in 2024 and 0.79 RMB in 2025 [10]. - The company’s price-to-earnings (P/E) ratio is projected to decrease from 230.60 in 2023 to 114.95 in 2025, indicating a potential valuation adjustment post-acquisition [10]. Market Position and Strategy - The company is positioned to capture a larger market share in the EMC sector, with current domestic market share below 5%. The acquisition of Hengsuo Huawai is expected to significantly enhance its market presence and operational capabilities [9][11]. - The company is actively working on advanced packaging materials, with several products undergoing customer validation, which could lead to new revenue streams in the future [7][11].

Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside in the stock price [5][11]. Core Insights - The company is a leading player in the epoxy encapsulation materials sector, with plans to acquire the top domestic competitor, enhancing its market position and production capacity [5][9]. - The company has achieved significant technological advancements, allowing it to compete effectively against foreign manufacturers in both traditional and advanced packaging sectors [7][11]. - The acquisition of Hengsuo Huawai is expected to double the company's revenue and profit, further solidifying its position in the market [9][11]. Company Overview - The company specializes in semiconductor materials, particularly epoxy encapsulation materials (EMC), which are crucial for protecting semiconductor chips [7]. - As of February 21, 2025, the company's stock price was 90.41 CNY, with a market capitalization of 46.51 billion CNY [2]. - The company has a diverse customer base, including major domestic packaging firms such as Changdian Technology and Huatian Technology [7]. Financial Performance - For the first half of 2024, the company reported revenue of 149 million CNY from the EMC segment, accounting for 95.72% of total revenue, with a gross margin of 27.40% [7]. - The company anticipates a net profit of 46 million CNY in 2024, with a year-on-year growth of 44.26% [10][11]. - The projected earnings per share (EPS) for 2024, 2025, and 2026 are 0.57 CNY, 0.79 CNY, and 0.95 CNY, respectively [10][11]. Market Position - The company holds a market share of less than 5% in the domestic EMC market but aims to increase this share through domestic substitution efforts [7][11]. - The company is positioned to benefit from the growing demand for advanced packaging materials, with several products currently undergoing customer validation [7][11]. Strategic Initiatives - The planned acquisition of Hengsuo Huawai is a strategic move to enhance market presence and operational efficiency, leveraging the management experience of the company's executives who have previously worked at Hengsuo Huawai [9][11]. - The company is also expanding its product offerings in electronic adhesives, which complement its EMC products and enhance its competitive edge in advanced packaging applications [11].

江苏华海诚科新材料股份有限公司 关于股份回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/12/31 | | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 12 个月 | | 预计回购金额 | 万元~5,000 万元 2,500 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | √用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | 万股 7.18 | | 累计已回购股数占总股本比 | 0.09% | | 例 | | | 累计已回购金额 | 599.97 万元 | | 实际回购价格区间 | 81.18 元/股~86.56 元/股 | 一、 回购股份的基本情况 证券代码：688535 证券简称：华海诚科 公告编号：2025-007 江苏华海诚科新材料股份有限公司（以下简称"公司"）于 2024 年 12 月 27 日 召开第三届董事会第二十一次会议，审议通过了《关于以集中竞价方 ...

证券代码:688535 证券简称:华海诚科 公告编号:2025-006 江苏华海诚科新材料股份有限公司 关于筹划发行股份、可转换公司债券及支付现金购买资产 并募集配套资金事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 本次交易尚需满足多项交易条件后方可实施,包括但不限于上市公司再次召 开董事会、召开股东大会审议通过本次交易、交易对方履行完全部必要的内部决 策程序、上海证券交易所审核通过、中国证监会同意注册等。本次交易能否取得 上述批准和注册,以及最终取得批准和注册的时间都存在不确定性。为保证信息 披露公平性，维护广大投资者利益，公司将严格按照相关法律法规的规定披露本 次交易事项的进展情况。有关信息均以公司指定信息披露媒体和上海证券交易所 网站(www.sse.com.cn)发布的公告为准。敬请广大投资者理性投资，注意投资风 险。 特此公告。 江苏华海诚科新材料股份有限公司(以下简称"公司"或"上市公司") 拟 以发行股份、可转换公司债券及支付现金的方式购买衡所华威电子有限公司(以 下简称"标的公司")70%股权 ...

华海诚科 2025年第一次临时股东大会 法律意见书 江苏世纪同仁律师事务所 关于江苏华海诚科新材料股份有限公司 2025 年第一次临时股东大会的法律意见书 江苏华海诚科新材料股份有限公司: 根据《公司法》《证券法》和中国证监会发布的《上市公司股东大会规则》 等法律、法规和规范性文件以及《公司章程》的规定,本所受公司董事会的委托, 指派本所律师出席公司 2025年第一次临时股东大会,并就本次股东大会的召集、 召开程序、出席会议人员资格、召集人资格、表决程序以及表决结果的合法有效 性等事项出具法律意见。 为出具本法律意见书,本所律师对本次股东大会所涉及的有关事项进行了审 查,查阅了相关会议文件,并对有关问题进行了必要的核查和验证。 本所律师同意将本法律意见书随公司本次股东大会决议一并公告,并依法对 本法律意见书承担相应的责任。 本所律师根据相关法律、法规和规范性文件的要求,按照律师行业公认的业 务标准、道德规范和勤勉尽责精神,出具法律意见如下: 一、关于本次股东大会的召集、召开程序 1.本次股东大会的召集 本次股东大会由董事会召集。2024年12月27日,公司召开了第三届董事 会第二十一次会议,决定于 2025年 ...

证券代码：688535 证券简称：华海诚科 公告编号：2025-004 江苏华海诚科新材料股份有限公司 2025 年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 1 月 15 日 （二） 股东大会召开的地点：江苏华海诚科新材料股份有限公司 306 会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 82 | | --- | --- | | 普通股股东人数 | 82 | | 2、出席会议的股东所持有的表决权数量 | 5,209,005 | | 普通股股东所持有表决权数量 | 5,209,005 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的 | 6.4550 | | 比例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例 | 6.4550 | | （%） | | ...